OptiBiotix Health (GB:OPTI) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
OptiBiotix Health plc is set to expand its market presence in India through a collaboration with Dr Morepen to launch the innovative LightLife brand, featuring SlimBiome® products aimed at addressing obesity and health issues. The partnership will leverage a substantial £1.5 million marketing investment, targeting a vast network of pharmacies and online platforms to capture a significant share of the growing Indian weight management market. This strategic move is expected to significantly boost OptiBiotix’s revenue, capitalizing on India’s expanding middle class and increasing health awareness.
For further insights into GB:OPTI stock, check out TipRanks’ Stock Analysis page.